Akorn's downfall amplifies shortage of asthma med albuterol, FDA warns

Akorn, the “sole manufacturer” of a certain dose of liquid albuterol, has stopped production, FDA tweeted Wednesday.  Two weeks ago, Akorn filed for bankruptcy and mothballed its U.S. operations. The closure swept up facilities like Akorn’s Decatur, Illinois, manufacturing plant, which was licensed to make the specific form of the drug in shortage.